Cargando…
Monoclonal antibodies in neuro-oncology: Getting past the blood-brain barrier
Monoclonal antibodies (mAbs) are used with increasing success against many tumors, but for brain tumors the blood-brain barrier (BBB) is a special concern. The BBB prevents antibody entry to the normal brain; however, its role in brain tumor therapy is more complex. The BBB is closest to normal at m...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092616/ https://www.ncbi.nlm.nih.gov/pubmed/21150307 http://dx.doi.org/10.4161/mabs.3.2.14239 |